Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06885320 · ClinicalTrials.gov registry record · NA
Building Undergraduate Coping & Knowledge for Stress-Resilience
A NA study, sponsored by Ohio State University.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT06885320 is a NA study that has completed, run by Ohio State University. The registered enrollment target is 40 participants.
The verdict
NCT06885320, a NA study, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
Nearly 60% of college students use alcohol and 30% binge drink monthly. This is alarming given that heavy alcohol use is linked to serious detrimental outcomes. Despite various prevention and intervention strategies, heavy alcohol use has remained relatively stable over the past decade. Individual differences in stress response connote risk for alcohol use disorder. Anxiety sensitivity (AS) and intolerance of uncertainty (IU) are two key cognitive vulnerabilities that can hinder resilience by amplifying stress responses and promoting maladaptive coping strategies, such as alcohol use. Effective stress management is a cornerstone of resilience. The Intervention for Managing Psychological Responding to Overwhelming Emotions (IMPROVE) targets AS and IU, key barriers to resilience, by modifying cognitive processes that amplify stress and negative affect. In this study, undergraduate students who engage in heavy drinking behaviors and experience elevated anxiety symptoms will be randomized to IMPROVE or a control health promotion intervention (N=20 per arm). All participants will complete daily ecological momentary assessments (EMA) delivered to participants' mobile phones to capture real-world alcohol use before, during, and after the intervention. The investigators will evaluate the feasibility and acceptability of IMPROVE (Aim 1). The investigators will also include a multimodal battery of self-report and objective lab-based measures of AS and IU involving startle eyeblink potentiation and event-related potentials via electromyography (EMG) and electroencephalography (EEG). This will allow the investigators to examine whether IMPROVE changes IU and AS, and to assess if changes in these targets are associated with changes in alcohol use (Aim 2).
Interventions
- BEHAVIORAL IMPROVE
- BEHAVIORAL HET
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-02-01 |
| Est. Completion | 2025-12-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06885320
The ClinicalTrials.gov registry entry for NCT06885320 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which IMPROVE is the first listed.
NCT06885320 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06885320 about?
NCT06885320 is a clinical study titled "Building Undergraduate Coping & Knowledge for Stress-Resilience". Nearly 60% of college students use alcohol and 30% binge drink monthly. This is alarming given that heavy alcohol use is linked to serious detrimental outcomes. Despite various prevention and intervention strategies, heavy alcohol use has remained relatively stable over the past decade. Individual d...
What is the current status of trial NCT06885320?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2025-02-01. Estimated completion is 2025-12-22.
What interventions are being tested in trial NCT06885320?
The interventions under investigation include: IMPROVE (BEHAVIORAL), HET (BEHAVIORAL).
Who is sponsoring clinical trial NCT06885320?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.